GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Question] the UK — has anyone got a straight answer on reimbursement — 13 comments in the full submission. View in context.
150
c/glp1eu·submitted 7 months ago by u/milan_mensah

[Question] the UK — has anyone got a straight answer on reimbursement

Questionbranch of 7 comments

the UK — has anyone got a straight answer on reimbursement, and I want the answer with the reasoning attached rather than just the conclusion. The structure that makes this board make sense, once. Marketing authorisation for these products is granted centrally, which is why the same product exists across the union.…

Read the full submission and all 13 comments →

This branch

7 comments, started 7 months ago
u/rt_shift_reggie21 points·7 months ago

Supply notices are issued nationally. A notice in one member state does not imply availability problems in another, even for the same product.

replysharereportpermalink
u/sten_bhattacharya17 points·7 months ago

Supply notices are issued nationally.

Agreed — and normalising pack size before comparing prices is the fix for half these threads.

replysharereportpermalink
u/fabio_ibarra0 points·7 months ago

That shortage notice was national and does not apply where the question is coming from.

replysharereportpermalink
u/wanjiru_ramos7 points·7 months ago

This. The published reimbursement criteria are the document to read, and most member states do publish them.

replysharereportpermalink
u/nikhil_asante3 points·7 months ago

Have you read the published reimbursement criteria where you are?

replysharereportpermalink
u/kaplan_meier_kim4 points·7 months ago·edited

Apotheke pricing and pharmacy pricing elsewhere are different systems

replysharereportpermalink
u/gastric_emptying_g2 points·7 months ago

a shortage in one member state is not a shortage in all of them

replysharereportpermalink

← back to the whole thread

About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.com
Sponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.